Linus Health improves cognitive care by providing tools for the early detection of Alzheimer's and other forms of dementia using artificial intelligence. Their main product is a digital cognitive assessment platform that combines traditional assessments with AI-driven neurological analysis, allowing healthcare providers to identify cognitive impairment more effectively. A key feature is DCTclock, an AI-enhanced version of the traditional clock drawing test, developed through research at MIT and Lahey. The company aims to address the growing need for dementia services and improve patient outcomes through early intervention.

Morningside Group

Morningside

AI & Machine Learning

Biotechnology

Healthcare

Linus Health

Neurogen Biomarking announces collaboration with Linus Health bringing easy access to cutting-edge technology to support early detection of Mild Cognitive Impairment and dementia due to Alzheimer's disease.

Neurogen Biomarking Announces Collaboration with Linus Health Bringing Easy Access to Cutting-Edge Technology to Support Early Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease

Brook Health, a leader in remote patient care and AI-powered health support, has officially announced a partnership with Linus Health, a digital health company enabling early detection of Alzheimer's and other dementias, to conceive a simplistic brand of cognitive care.

Enabling the Field of Cognitive Care to be Less Cumbersome

As HLTH 2024 prepares to convene in Las Vegas, the anticipation for groundbreaking insights and transformative discussions is palpable. To get a glimpse into the key themes and predictions shaping this year’s event, we reached out to 21 digital health executives for their expert perspectives.From the rise of generative AI and the evolving role of virtual care to the increasing focus on health equity and value-based care, these industry leaders offer a diverse range of perspectives on the most pressing challenges and promising opportunities facing the healthcare ecosystem.Join us as we delve into their predictions and explore the trends that are poised to redefine the future of healthcare at HLTH 2024.Ryne Natzke, chief revenue officer, TrustCommerce, a Sphere company, a provider of end-to-end integrated healthcare payments and security softwareAI, AI, and more AI! I’m looking forward to seeing how AI is being applied to help clinicians, patients, and other staff members provide better patient experiences and outcomes. Everything is moving so quickly that it will be exciting to get an update on where the industry is going.James Aita, director, Strategy and Business Development, Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutionsOf course AI is the hot topic at HLTH this year–but with the new regulations from ASTP/ONC, the question is how can it be usable, trustworthy, transparent and helpful. I’m also interested in seeing who else is making AI and clinical data helpful at the point of care to reduce the burden on clinicians and inform patient care.Lyle Berkowitz, MD, CEO, KeyCare, the nation’s first Epic-based virtual care companyI always look forward to HLTH and seeing presentations of the newest cutting-edge technology and ideas. This year, I’m expecting deeper and wider use cases of AI to lead the charge. But in addition to technology innovations, I’m also hoping we will hear about other people and process topics such as how to set up virtual care teams and how to rethink primary care physician compensation to better align around adoption of automation and team-based care.Kazu Okuda, MD, CEO and co-founder of Universal Brain, whose platforms use brain-function measurement to drive precision psychiatryThe emergence of personalized treatment is an exciting field that I expect to take center stage at HLTH this year

Hlth 2024: 21 Executives Share Their Predictions And Insights

Linus Health to unveil new tools for earlier dementia detection at aafp's FMX '24.

Linus Health to Unveil New Tools for Earlier Dementia Detection at AAFP's FMX '24

PHILADELPHIA, July 30, 2024 /PRNewswire/ -- uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer's and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning.With the increasing prevalence of cognitive impairment, including Alzheimer's and other dementias, there is a critical need for innovative solutions that bridge the gap between assessment, diagnosis, and actionable care. The combined solution simplifies the complexities of clinical workflows, offering precise insights for healthcare providers to deliver more effective care across their patient populations.Closing Care Gaps with Advanced TechnologiesThe collaboration between uMethod Health and Linus Health empowers clinicians with:Comprehensive cognitive assessments : Linus Health's state-of-the-art digital health platform offers advanced cognitive assessments that leverage artificial intelligence to provide accurate and timely evaluations of memory and executive function.: Linus Health's state-of-the-art digital health platform offers advanced cognitive assessments that leverage artificial intelligence to provide accurate and timely evaluations of memory and executive function. Personalized care planning : uMethod Health's innovative platform creates individualized care plans based on a patient's unique cognitive profile, biomarkers, and medical history, ensuring tailored interventions and treatments.: uMethod Health's innovative platform creates individualized care plans based on a patient's unique cognitive profile, biomarkers, and medical history, ensuring tailored interventions and treatments. Streamlined workflows: The combined strength of both platforms seamlessly guides clinicians from assessment to care planning, reducing administrative burdens and enhancing clinical efficiency.Empowering Patients and ClinicsBoth uMethod Health and Linus Health are committed to equipping clinicians and patients with the tools they need to navigate complex cognitive care with the integrated solution, which offers:Enhanced patient engagement : Patients gain access to clear, personalized care plans that empower them to take an active role in their cognitive health.: Patients gain access to clear, personalized care plans that empower them to take an active role in their cognitive health. Help improve clinical outcomes : Clinicians benefit from precise, data-driven insights that support early diagnosis and effective intervention.: Clinicians benefit from precise, data-driven insights that support early diagnosis and effective intervention

Umethod Health Collaborates With Linus Health To Streamline Digital Brain Health Assessment + Cognitive Care Planning

Company's virtual therapeutic programs and proprietary risk stratification algorithm support proactive detection of and intervention for cognitive declineBOSTON, July 24, 2024 /PRNewswire/ -- Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer's and other dementias, today announced its acquisition of Together Senior Health (Together), a brain health company delivering evidence-based solutions for individuals with cognitive decline, Alzheimer's disease and related dementias. Together will be a wholly-owned subsidiary of Linus Health.Together is the creator of the Moving Together™ program, the first scientifically-validated virtual therapeutic program that combines gentle movement, mindful body awareness, music, and social interaction tailored to how people with cognitive decline learn and engage. The Moving Together program is grounded in 10+ years of clinical research with the University of California, San Francisco, and the National Institutes of Health.The acquisition also includes Risk of Alzheimer's and Dementia AlgoRithm (RADAR), a proprietary cognitive-impairment identification and stratification algorithm. RADAR allows health insurers and healthcare provider organizations to identify their members or patients at highest risk for having undiagnosed Alzheimer's disease, dementia, and cognitive decline using claims data, electronic health record information, and other relevant data."Together Senior Health joining Linus Health is an ideal fit because both of our platforms are designed to detect and slow cognitive decline through personalized, lifestyle-focused interventions," said Together Co-Founder and Chief Science Advisor Deborah Barnes, PhD, MPH, who will serve as a consultant to Linus. "Combining our multidisciplinary knowledge and expertise with Linus Health's market-leading solutions will lead to many more people maintaining their cognitive function and independence for longer, reducing emergency department visits, and improving the well-being of individuals with cognitive decline and their care partners."A recent journal article co-authored by Barnes shared the results of a clinical trial investigating Moving Together, which showed significantly improved quality of life for participants with dementia and significantly improved ability to manage stress for their caregivers. Participants also experienced 30% fewer falls

Linus Health Acquires Together Senior Health To Expand Its Platform To Better Serve Patients And Providers With End-To-End Workflow Capabilities

Life sciences platform enhanced to make cognitive assessments easier and more preciseBOSTON, July 24, 2024 /PRNewswire/ -- Linus Health, a digital health company focused on enabling early detection of cognitive impairment, Alzheimer's and other dementias, will be presenting more than a dozen sessions and posters at the Alzheimer's Association International Conference (AAIC) taking place July 28-Aug. 1 in Philadelphia, and virtually.The Linus team will be at Booth #830 to discuss its cutting-edge Alzheimer's research as well as share updates and provide hands-on demonstrations of new assessments added to the company's brain health platform. Foremost among these significant enhancements are:A patent-pending amyloid predictor that estimates the likelihood of A𝛽 PET positive status based on a machine-learning model using various multi-modal drawing, voice and speech, and stylus measures obtained during Digital Clock & Recall assessment.A pre-screening platform that reduces the burden on participants and provides a rapid, low-cost solution for more randomized participant selection using a two-phased approach to enhance recruitment with short eligibility assessments that efficiently eliminate ineligible participants. Its remote capabilities broaden study populations to ensure the correct balance of participants and diversity for each study.An electronic Person Specific Outcome Measure (ePSOM™) tool to capture and monitor patient-reported outcomes in studies and enable true personalized recommendations and interventions.The research topics that Linus thought leaders will present at AAIC range from using artificial intelligence (AI) in digital cognitive assessment tools to the integration of a digital cognitive assessment tool in a primary care setting."Clinicians and researchers are on the cusp of breakthroughs in the detection and treatment of dementia," said Linus Health CEO and Co-Founder David Bates, PhD. "Conferences like AAIC are prime opportunities to share research and insights fueling those advancements, including Linus Health's groundbreaking research into dementia screening and the importance of early intervention for mild cognitive impairment."The pre-conference sessions are:"The Electronic Person-Specific Outcome Measure (ePSOM) in the US population: What Matters to Individuals the Most About Their Brain Health," by Stina Saunders , PhD, Personalized Medicine Lead, Linus Health. Saturday, July 27 ., PhD, Personalized Medicine Lead, Linus Health

Aaic 2024: Linus Health To Unveil Groundbreaking Research At Leading Alzheimer'S Conference

What You Should Know:– Linus Health, a leader in early detection of cognitive decline and dementia, announced today the acquisition of Together Senior Health. This strategic move strengthens Linus Health’s position in the brain health space by combining its expertise in early detection with Together’s evidence-based solutions for managing cognitive decline.– The post-acquisition integration process will prioritize a smooth transition for clients of both companies. Clients can continue to rely on their existing support representatives throughout this phase. Financial details of the acquisition were not disclosed.Addressing Growing Demand and Care GapsThe global dementia burden is anticipated to surge, with cases projected to climb from 55 million in 2020 to over 139 million by 2050. At the same time, the number of neurologists is struggling to keep pace with this rising demand. Linus Health’s brain health platform addresses these gaps by enabling early detection and intervention in primary care settings

Linus Health Acquires Together Senior Health, Bolstering Early Detection And Care For Cognitive Decline

Linus Health Introduces Person-Centered Approach to Establish Clinically Meaningful Benefits and Personalized Brain Health Care. Scalable, systematic and automated process captures and monitors metrics based on patients' treatment priorities for managing Alzheimer's disease and related dementiasBOSTON, June 25, 2024 -- Clinical and research leaders from Linus Health, a digital health company enabling early detection of Alzheimer's and other dementias, recently co-authored a peer-reviewed paper. The article describes a technology-enabled, scalable approach to guide clinical decisions and outcome evaluations about brain health that effectively incorporate patients' treatment priorities. The perspective paper, "Towards a lifelong personalized brain health program: empowering individuals to define, pursue, and monitor meaningful outcomes," was published on June 4 in Frontiers in Neurology. Linus Health authors include lead author Stina Saunders, PhD, who leads Linus' personalized medicine efforts, as well as Alvaro Pascual-Leone, MD, PhD, chief medical officer and co-founder, and John Showalter, MD, chief strategy officer

Linus Health Introduces Person-Centered Approach To Establish Clinically Meaningful Benefits And Personalized Brain Health Care

Digital platform for cognitive assessments

Linus Health

Digital platform for cognitive assessments

Linus Health

Digital platform for cognitive assessments

About

Simplify's Take

What believers are saying

What critics are saying

What makes Linus Health unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Linus Health is Hiring for 0 Jobs on Simplify!